作為腺苷A3受體配體的三唑并[1,5-a]喹啉類

• 收藏
• 分享

专利权人:

SANOFI-AVENTIS

发明人:

SUSAN, EDIT,苏珊迪,蘇珊迪,BOER, KINGA,包尔金,包爾金,KAPUI, ZOLTAN,凯普毅,凱普毅,TIMARI, GEZA,廷亚瑞,廷亞瑞,BATORI, SANDOR,巴特瑞,SZLAVIK, ZOLTAN,史维克,史維克,MIKUS, ENDRE,米酷斯,VARGANE SZEREDI, JUDIT,凡盖恩,凡蓋恩,FINET, MICHEL,芬妮特

申请号：

TW097121025

公开号：

TWI424998B

申请日:

2008.06.06

申请国别(地区):

TW

年份:

2014

代理人:

摘要：

The present invention relates to the adenosine A3receptor ligands of the general formula(I),within them favourably to the antagonists, to their salts, solvates, N-oxides and isomers, to the pharmaceutical compositions containing the compounds of the general formula (I), their salts, solvates, N-oxides and isomers, to the use of the compounds of the general formula (I), their salts, solvates, N-oxides and isomers, to the preparation of the compounds of the general formula (I), their salts, solvates, N-oxides and isomers, as well as to the new intermediates of the general formula (II), (VI), (XI), (XII) and (XV), and to the preparation thereof.本發明係關於通式(I)之腺苷A3受體配體，其中有利地係關於拮抗劑，其鹽類、溶劑化物、N－氧化物及異構物，含有通式(I)化合物、其鹽類、溶劑化物、N－氧化物及異構物之醫藥組合物，通式(I)化合物、其鹽類、溶劑化物、N－氧化物及異構物之用途，通式(I)化合物、其鹽類、溶劑化物、N－氧化物及異構物之製備，以及通式(II)、(VI)、(XI)、(XII)及(XV)之新穎的中間物及其製備。

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/